Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobank

Fibrosis status, extrahepatic multimorbidity and all-cause mortality in 53,093 women and 74,377 men with metabolic dysfunction associated steatotic liver disease (MASLD) in UK biobank

Abstract Introduction People with metabolic-dysfunction associated steatotic liver disease (MASLD) had higher risk of extrahepatic multimorbidity, and fibrosis is the strongest prognostic factor for mortality in MASLD. This study aimed to investigate how fibrosis was associated with multimorbidity a...

Full description

Saved in:
Bibliographic Details
Main Authors: Qi Feng, Chioma N. Izzi-Engbeaya, Pinelopi Manousou, Mark Woodward
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Gastroenterology
Subjects:
MASLD
Fibrosis
FIB4
Multimorbidity
Mortality
UK biobank
Online Access:https://doi.org/10.1186/s12876-025-04079-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12876-025-04079-4

Similar Items